ArticleMolecules (Basel, Switzerland)2023
Molecular Property Prediction of Modified Gedunin Using Machine Learning.
Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Metaheuristic hyperparameter optimization of deep neural networks for demographic-aware autism spectrum disorder classification.Scientific reports · 2026Article
- A comprehensive deep learning framework for real time emotion detection in online learning using hybrid models.Scientific reports · 2025Article
- SHAP enhanced transformer GWO boosting model for transparent and robust anomaly detection in IIoT environments.Scientific reports · 2025Article
- Enhancing anomaly detection in IoT-driven factories using Logistic Boosting, Random Forest, and SVM: A comparative machine learning approach.Scientific reports · 2025Article
- Recognizing American Sign Language gestures efficiently and accurately using a hybrid transformer model.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Images of molecules are often utilized in education and synthetic exploration to predict molecular characteristics. Deep learning (DL) has also had an influence on drug research, such as the interpretation of cellular images as well as the development of innovative methods for the synthesis of organic molecules. Although research in these areas has been significant, a comprehensive review of DL applications in drug development would be beyond the scope of a single Account. In this study, we will concentrate on a single major area where DL has influenced molecular design: the prediction of molecular properties of modified gedunin using machine learning (ML). AI and ML technologies are critical in drug research and development. In these other words, deep learning (DL) algorithms and artificial neural networks (ANN) have changed the field. In short, advances in AI and ML present a good potential for rational drug design and exploration, which will ultimately benefit humanity. In this paper, long short-term memory (LSTM) was used to convert a modified gedunin SMILE into a molecular image. The 2D molecular representations and their immediately visible highlights should then provide adequate data to predict the subordinate characteristics of atom design. We aim to find the properties of modified gedunin using K-means clustering; RNN-like ML tools. To support this postulation, neural network (NN) clustering based on the AI picture is used and evaluated in this study. The novel chemical developed via profound learning has long been predicted on characteristics. As a result, LSTM with RNNs allow us to predict the properties of molecules of modified gedunin. The total accuracy of the suggested model is 98.68%. The accuracy of the molecular property prediction of modified gedunin research is promising enough to evaluate extrapolation and generalization. The model suggested in this research requires just seconds or minutes to calculate, making it faster as well as more effective than existing techniques. In short, ML can be a useful tool for predicting the properties of modified gedunin molecules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.